58166-38-4

Basic information

• Product Name: 4-Thiazolidinecarboxylic acid, 2,2-dimethyl-, (4R)-
• CAS NO: 58166-38-4
• Molecular Formula: C6H11NO2S
• Molecular Weight: 161.225
• Mol File: 58166-38-4.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: 4-Thiazolidinecarboxylic acid, 2,2-dimethyl-, (4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Thiazolidinecarboxylic acid, 2,2-dimethyl-, (4R)-(58166-38-4)
• EPA Substance Registry System: 4-Thiazolidinecarboxylic acid, 2,2-dimethyl-, (4R)-(58166-38-4)

Safety Data

• Hazardous Substances Data: 58166-38-4(Hazardous Substances Data)

Upstream product

• 52-89-1 l-cysteine hydrochloride 
• 67-64-1 acetone 
• 921-01-7 D-cysteine 
• 52-90-4 L-Cysteine 

Downstream Products

• 869002-29-9 N-benzyloxycarbonylglycyl-L-4-thia-5,5-dimethylproline 
• 5317-17-9 (4R)-5t-(N,N'-bis-methoxycarbonyl-hydrazino)-2,2-dimethyl-thiazolidine-3,4r-dicarboxylic acid 3-tert-butyl ester 4-methyl ester 
• 74527-65-4 N-((R)-3-formyl-2,2-dimethyl-thiazolidine-4-carbonyl)-glycine 
• 99167-92-7 (+/-)-N-(3-formyl-2,2-dimethyl-thiazolidine-4-carbonyl)-glycine-methyl ester 
• 81355-92-2 (R)-3-formyl-2,2-dimethyl-thiazolidine-4-carboxylic acid anilide 
• 185950-57-6 phenacyl (R)-2-(3-t-butoxycarbonyl-2,2-dimethylthiazolidin-4-yl)thiazole-4-carboxylate 
• 380149-70-2 Fmoc-Tyr(All)-Cys(Ψ^Me,Mepro)-OH 
• 19907-59-6 methyl (4R)-2,2-dimethylthiazolidine-4-carboxylate 
• 158531-43-2 Fmoc-Ala-Cys(ψMe,Me-pro)-OH 
• 82625-84-1 (4R)-3-<(2S)-S-benzoyl-3-mercapto-2-methylpropanoyl>-2,2-dimethyl-4-thiazolidinecarboxylic acid 
• 82625-83-0 (4R)-3-(S-benzoyl-3-mercaptopropanoyl)-2,2-dimethyl-4-thiazolidinecarboxylic acid 
• 55878-44-9 L-4-carboxy-3-formyl-2,2-dimethylthiazolidine 
• 102889-84-9 (R)-2,2-dimethyl-3-(N,N-phthaloyl-L-phenylalanyl)-thiazolidine-4-carboxylic acid 
• 196930-46-8 (4R)-2-phenyl-1,3-thiazolidine-4-carboxylic acid 

Relevant articles and documents

Improved method for synthesis of cysteine modified hyaluronic acid for in situ hydrogel formation

We developed a new strategy for the functionalization of hyaluronic acid by chemical modification of its C-6 hydroxyl groups through an ether bond to obtain a cysteine-hyaluronic acid conjugate. This conjugate is suitable to prepare injectable and in situ formed hydrogels cross-linked by native chemical ligation and Michael addition under mild conditions.

SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES

The present disclosure relates generally to the field of polypeptide synthesis, and more particularly, to the solution phase synthesis of the Wnt hexapeptide Foxy-5 and protected derivatives and peptide fragments thereof.

Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism

A series of novel curcumin analogs, symmetrical dienones, were previously shown to possess cytotoxic, anti-angiogenic and anti-tumor activities. Analogs 1 (EF24) and 2 (EF31) share the dienone scaffold and serve as Michael acceptors. We propose that the anti-cancer effects of 1 and 2 are mediated in part by redox-mediated induction of apoptosis. In order to support this concept, 1 and 2 were treated with l-glutathione (GSH) and cysteine-containing dipeptides under mild conditions to form colorless water-soluble adducts, which were identified by LC/MS. Comparison of the cytotoxic action of 1, 2 and the corresponding conjugates, 1-(GSH)2 and 2-(GSH)2, illustrated that the two classes of compounds exhibit essentially identical cell killing capabilities. Compared with the yellow, somewhat light sensitive and nearly water insoluble compounds 1 and 2, the glutathione conjugates represent a promising new series of stable and soluble anti-tumor pro-drugs.